US$ 23.96
pnb-0408 dihexa human trial Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects Dihexa/Hexanoyl-Tyr-Ile-Ahx-NH2/N-hexanoic-Try-Ile-(6)-amino hexanoic amide/ PNB-0408 1401708-83-5
Description
You can also read the full article PDF here: Pain Physician full-text PDF
You wont need injections as often because youre just topping off your bodys supply

However, some patients report sleep disturbances that may be indirectly related to gastrointestinal symptoms or metabolic changes during treatment

MIC B12 combines methionine, inositol, choline, and cyanocobalamin to support metabolism and energy

Y2 -} !Y0

A common protocol involves administering 1,000 mcg of B12 weekly for 4 to 8 weeks, depending on the deficiencys severity and the patients response
